{
    "code": "60001186",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001186",
    "time": "2024-01-11 21:54:58",
    "許可證字號": "衛部菌疫輸字第001186號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/02\/07",
    "發證\/登錄日期": "111\/02\/07",
    "許可證\/登錄種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA06000118601",
    "中文品名": "安潰悠皮下注射劑108毫克",
    "英文品名": "Entyvio 108mg Solution for Injection",
    "適應症": "適用於治療以下的成人病人：\r\n(1)中度至重度活性潰瘍性結腸炎。\r\n(2)中度至重度活性克隆氏症。\r\n對腫瘤壞死因子(TNF)阻斷劑或免疫調節藥物治療反應不佳、失去治療反應或無法耐受；或對皮質類固醇治療反應不佳、無法耐受或證實發生依賴性。",
    "劑型": "27D注射液劑",
    "包裝": "0.68毫升預充填注射針筒裝、0.68毫升預充填注射筆裝，100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "基因工程產品_新使用途徑;",
    "監視期限": "116\/02\/07",
    "主成分略述": "Vedolizumab",
    "限制項目": "02輸　入 1D須執行風險管理計畫",
    "申請商名稱": "台灣武田藥品工業股份有限公司",
    "申請商地址": "台北市信義區松高路1號17樓",
    "主製造廠": [
        {
            "製造廠名稱": "VETTER PHARMA-FERTIGUNG GMBH &amp; CO KG",
            "製造廠廠址": "MOOSWIESEN 2, 88214 RAVENSBURG, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "成品製造廠、預充填注射針筒組裝廠"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "TAKEDA AUSTRIA GMBH",
            "製造廠廠址": "ST. PETER-STRASSE 25 A-4020 LINZ, AUSTRIA",
            "製造廠公司地址": "",
            "製造廠國別": "AUSTRIA",
            "製程": "包裝廠、預充填注射針筒及預充填注射筆組裝廠"
        },
        {
            "製造廠名稱": "LONZA BIOLOGICS, INC.",
            "製造廠廠址": "101 INTERNATIONAL DRIVE PEASE INTERNATIONAL TRADEPORT PORTSMOUTH, NEW HAMPSHIRE, U.S. 03801",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "AbbVie Bioresearch Center",
            "製造廠廠址": "100 Research Drive, Worcester, MA 01605, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200082200",
            "成分名稱": "Vedolizumab",
            "含量描述": "",
            "含量": "108.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "202203015 Entyvio SC PI TW仿單-111-03-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001186&Seq=001&Type=9"
        },
        {
            "title": "Entyvio NSD外盒標籤-111-03-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001186&Seq=002&Type=8"
        },
        {
            "title": "Entyvio AI 外盒標籤-111-03-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001186&Seq=001&Type=8"
        }
    ]
}